Perchlorate

Perchlorate

SCHEMBL4887854

Oc1ccc2ccccc2c1/C=C/c1ccc2ccccc2[n+]1-c1ccccc1.[O-][Cl+3]([O-])([O-])[O-]

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.45
KMT2A Q03164 7/20 0.45
KDM4E B2RXH2 7/20 0.45
L3MBTL1 Q9Y468 6/20 0.45
ALDH1A1 P00352 6/20 0.45
MEN1 O00255 5/20 0.45
THRB P10828 4/20 0.45
NPC1 O15118 3/20 0.45
HTT P42858 3/20 0.45
POLB P06746 3/20 0.45
RAB9A P51151 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
BLM P54132 2/20 0.45
LMNA P02545 1/20 0.45
HSP90AA1 P07900 1/20 0.45
XBP1 P17861 1/20 0.45
MAPK1 P28482 1/20 0.45
PPARG P37231 1/20 0.45
RECQL P46063 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Perchlorate SCHEMBL5267081 1.00 MAPT (0.45) MAPTKMT2AKDM4EL3MBTL1ALDH1A1
Perchlorate SCHEMBL4886286 0.84 ACHE (0.54) MAPTKMT2AKDM4EALDH1A1MEN1
Perchlorate SCHEMBL4886261 0.84 ACHE (0.54) MAPTKMT2AKDM4EALDH1A1MEN1
Perchlorate SCHEMBL4887190 0.81 ECE2 (0.43) MAPTKMT2AKDM4EL3MBTL1ALDH1A1
Perchlorate SCHEMBL4887197 0.81 ECE2 (0.43) MAPTKMT2AKDM4EL3MBTL1ALDH1A1
SCHEMBL5267077 0.81 NPC1 (0.43) MAPTKMT2AKDM4EL3MBTL1ALDH1A1
Perchlorate SCHEMBL4882254 0.75 KMT2A (0.44) MAPTKMT2AKDM4EL3MBTL1ALDH1A1
Perchlorate SCHEMBL4882267 0.75 KMT2A (0.44) MAPTKMT2AKDM4EL3MBTL1ALDH1A1
SCHEMBL7915285 0.74 ERN1 (0.70) MAPTKMT2AKDM4EL3MBTL1ALDH1A1
SCHEMBL7915280 0.74 ERN1 (0.70) MAPTKMT2AKDM4EL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080281105-A1 Novel Quinolinium Salts and Derivatives IMMUSOL INCORPORATED (US) 2008-11-13 US disclosed
EP-1841428-A1 NOVEL QUINOLINIUM SALTS AND DERIVATIVES Immusol Incorporated (US) 2007-10-10 EP disclosed
WO-2006078754-A1 NOVEL QUINOLINIUM SALTS AND DERIVATIVES IMMUSOL INCORPORATED (US) 2006-07-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080281105-A1 Novel Quinolinium Salts and Derivatives NQO2, MCL1, KRAS MAPT 2491/4885KMT2A 944/4885KDM4E 2336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.